Rad A Ehteshami, Kallmes D F
Department of Radiology, Mayo Clinic, Rochester, MN 55905, USA.
AJNR Am J Neuroradiol. 2008 Oct;29(9):1622-6. doi: 10.3174/ajnr.A1186. Epub 2008 Jun 26.
Focal point tenderness over the fractured level is believed to be a necessary criterion for performing vertebroplasty. The purpose of this study was to explore whether the presence of focal-point tenderness over a fracture treated with vertebroplasty predicts superior clinical outcome as compared with outcomes in patients without such tenderness.
In this retrospective study, we divided patients into 3 groups on the basis of pain patterns noted during history and physical examination before an initial vertebroplasty in 534 consecutive patients. Group 1 comprised 373 (70%) of 534 patients with focal-point tenderness over the treated fractures. Group 2 comprised 119 (22%) patients with focal-point tenderness over the treated fractures as well as subjective off-midline pain or focal tenderness to palpation over nontreated vertebrae. Group 3 comprised 42 (8%) patients without focal-point tenderness over the treated fractures but with subjective off-midline pain or tenderness to palpation over nontreated vertebrae. Outcomes included pain at rest and with activity as well as the Roland-Morris Disability Questionnaire score. Statistical tools included the 2-tailed t test with a Bonferroni adjustment.
Baseline pain at rest and with activity was not different among groups, but the proportion of group 3 patients maintained on a narcotic anesthesia preprocedure was less than that of groups 1 and 2 (P = .02 compared with both groups). Group 3 achieved significantly lower pain scores at rest at 1 month (P < .0001 compared with group 1 and P < .001 compared with group 2).
The presence of focal-point tenderness does not predict superior clinical response following vertebroplasty compared with the absence of focal tenderness. Even patients without focal tenderness may benefit from vertebroplasty.
骨折部位的局限性压痛被认为是进行椎体成形术的必要标准。本研究的目的是探讨椎体成形术治疗的骨折部位存在局限性压痛的患者与无此类压痛的患者相比,是否预示着更好的临床结局。
在这项回顾性研究中,我们根据534例连续接受初次椎体成形术的患者在病史和体格检查中记录的疼痛模式将患者分为3组。第1组包括534例患者中的373例(70%),其治疗骨折部位有局限性压痛。第2组包括119例(22%)患者,其治疗骨折部位有局限性压痛,同时伴有主观的中线外疼痛或未治疗椎体触诊时的局限性压痛。第3组包括42例(8%)患者,其治疗骨折部位无局限性压痛,但有主观的中线外疼痛或未治疗椎体触诊时的压痛。结局指标包括静息和活动时的疼痛以及罗兰-莫里斯功能障碍问卷评分。统计工具包括经Bonferroni校正的双尾t检验。
各组静息和活动时的基线疼痛无差异,但术前持续使用麻醉剂的第3组患者比例低于第1组和第2组(与两组相比,P = .02)。第3组在1个月时静息时的疼痛评分显著更低(与第1组相比,P < .0001;与第2组相比,P < .001)。
与无局限性压痛相比,存在局限性压痛并不能预示椎体成形术后更好的临床反应。即使没有局限性压痛的患者也可能从椎体成形术中获益。